Induction of bilirubin-eliminating processes by methylphenobarbital in mature newborn babies.

Abstract

In order to find a drug for the prevention of metabolic hyperbilirubinemia of the newborn, which has less sedative effects than phenobarbital (PB) the effect of methylphenobarbital (MPB) on the plasma bilirubin concentration of newborns was studied in a double blind trial. MPB (3 x 10 mg/kg on the first day) reduced the plasma bilirubin level in mature newborns on day four by 33% in comparison to those on placebo. The results justify further investigations in premature babies, who frequently suffer from disturbances which may facilitate the development of bilirubin encephalopathy.

• Authors: L Grauel, M Almanza, R Alvarez, D Garcia, I Gonzales, I Grimmer, I Körner
• Journal: Journal of perinatal medicine (J Perinat Med) Vol. 16 Issue 5-6 Pg. 431-5 ( 1988) ISSN: 0300-5577 [Print] Germany
• PMID: 3241289 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)

Chemical References

• Mephobarbital
• Racemases and Epimerases
• Bilirubin

Topics

• Bilirubin (blood)
• Birth Weight
• Double-Blind Method
• Female
• Gestational Age
• Humans
• Infant, Newborn
• Jaundice, Neonatal (blood, drug therapy)
• Male
• Mephobarbital (therapeutic use)
• Racemases and Epimerases